Literature DB >> 25751889

Structure of bone morphogenetic protein 9 procomplex.

Li-Zhi Mi1, Christopher T Brown2, Yijie Gao2, Yuan Tian3, Viet Q Le3, Thomas Walz4, Timothy A Springer5.   

Abstract

Bone morphogenetic proteins (BMPs) belong to the TGF-β family, whose 33 members regulate multiple aspects of morphogenesis. TGF-β family members are secreted as procomplexes containing a small growth factor dimer associated with two larger prodomains. As isolated procomplexes, some members are latent, whereas most are active; what determines these differences is unknown. Here, studies on pro-BMP structures and binding to receptors lead to insights into mechanisms that regulate latency in the TGF-β family and into the functions of their highly divergent prodomains. The observed open-armed, nonlatent conformation of pro-BMP9 and pro-BMP7 contrasts with the cross-armed, latent conformation of pro-TGF-β1. Despite markedly different arm orientations in pro-BMP and pro-TGF-β, the arm domain of the prodomain can similarly associate with the growth factor, whereas prodomain elements N- and C-terminal to the arm associate differently with the growth factor and may compete with one another to regulate latency and stepwise displacement by type I and II receptors. Sequence conservation suggests that pro-BMP9 can adopt both cross-armed and open-armed conformations. We propose that interactors in the matrix stabilize a cross-armed pro-BMP conformation and regulate transition between cross-armed, latent and open-armed, nonlatent pro-BMP conformations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751889      PMCID: PMC4378411          DOI: 10.1073/pnas.1501303112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions.

Authors:  E Krissinel; K Henrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix.

Authors:  William S Pietrzak; Jennifer Woodell-May; Nicholas McDonald
Journal:  J Craniofac Surg       Date:  2006-01       Impact factor: 1.046

3.  Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.

Authors:  Roselyne Castonguay; Eric D Werner; Robert G Matthews; Eleonora Presman; Aaron W Mulivor; Nicolas Solban; Dianne Sako; R Scott Pearsall; Kathryn W Underwood; Jasbir Seehra; Ravindra Kumar; Asya V Grinberg
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

4.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

5.  Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands.

Authors:  Craig A Harrison; Sara L Al-Musawi; Kelly L Walton
Journal:  Growth Factors       Date:  2011-08-24       Impact factor: 2.511

6.  The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix.

Authors:  Kate E Gregory; Robert N Ono; Noe L Charbonneau; Chiu-Liang Kuo; Douglas R Keene; Hans Peter Bächinger; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

7.  BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.

Authors:  Marie Bidart; Nicolas Ricard; Sandrine Levet; Michel Samson; Christine Mallet; Laurent David; Mariela Subileau; Emmanuelle Tillet; Jean-Jacques Feige; Sabine Bailly
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

8.  Crystal structure of BMP-9 and functional interactions with pro-region and receptors.

Authors:  Monica A Brown; Qinghai Zhao; Kent A Baker; Chethana Naik; Cecil Chen; Laurie Pukac; Mallika Singh; Tatiana Tsareva; Yanick Parice; Angela Mahoney; Viktor Roschke; Indra Sanyal; Senyon Choe
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

9.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.

Authors:  Marion Scharpfenecker; Maarten van Dinther; Zhen Liu; Rutger L van Bezooijen; Qinghai Zhao; Laurie Pukac; Clemens W G M Löwik; P ten Dijke
Journal:  J Cell Sci       Date:  2007-02-20       Impact factor: 5.285

Review 10.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

View more
  48 in total

1.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 2.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 3.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

Review 4.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

5.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

Review 6.  Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family.

Authors:  Sun Kyung Kim; Morkos A Henen; Andrew P Hinck
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-10

Review 7.  ALK1 signaling in development and disease: new paradigms.

Authors:  Beth L Roman; Andrew P Hinck
Journal:  Cell Mol Life Sci       Date:  2017-09-04       Impact factor: 9.261

Review 8.  Targeting TGF-β Signaling for Therapeutic Gain.

Authors:  Rosemary J Akhurst
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

Review 9.  Structure-guided engineering of TGF-βs for the development of novel inhibitors and probing mechanism.

Authors:  Andrew P Hinck
Journal:  Bioorg Med Chem       Date:  2018-07-07       Impact factor: 3.641

10.  Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.

Authors:  Edward N Anderson; Kristi A Wharton
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.